About Us
Our Mission & Values
Leadership Team
Board of Directors
Partners
Corporate Giving
Responsibility
Press Releases
Medicines
Science
Pipeline
Clinical Trials
Publications
Treatment Access
Patients & Caregivers
Our Commitment to Patients
Patient Voices
CKD with Hyperphosphatemia
IBS-C
Chronic Idiopathic Constipation
Join Us
Working at Ardelyx
Benefits
Open Positions
Medical Professionals
Investors & Media
About Us
Our Mission & Values
Leadership Team
Board of Directors
Partners
Corporate Giving
Responsibility
Press Releases
Medicines
Science
Pipeline
Clinical Trials
Publications
Treatment Access
Patients & Caregivers
Our Commitment to Patients
Patient Voices
CKD with Hyperphosphatemia
IBS-C
Chronic Idiopathic Constipation
Join Us
Working at Ardelyx
Benefits
Open Positions
Medical Professionals
Investors & Media
Publications
Disease Area
Hyperphosphatemia
IBS-C
Year
All
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Filter
Tenapanor Effectiveness for Treating Hyperphosphatemia in Patients Receiving Maintenance Dialysis: a Plain Language Summary of the OPTIMIZE Study
Current Medical Research and Opinion
Tenapanor Improves Long-term Control of High Phosphate Concentrations in the Blood in Patients Receiving Maintenance Dialysis: a Plain Language Summary of the NORMALIZE Study
Current Medical Research and Opinion
Long-Term Safety of Tenapanor in Patients with Irritable Bowel Syndrome with Constipation in the T3MPO-3 Study: Plain Language Summary of the Publication
Therapeutic Advances in Gastroenterology
An Overview of the Effects of Tenapanor on Visceral Hypersensitivity in the Treatment of Irritable Bowel Syndrome with Constipation
Clinical and Experimental Gastroenterology
Abdominal Symptom Improvement During Clinical Trials of Tenapanor in Patients with Irritable Bowel Syndrome with Constipation: A Post Hoc Analysis
The American Journal of Gastroenterology
Pages:
1
2
3
4
5
6
7
8
9
Load More
Sorry, nothing found in this query